506 related articles for article (PubMed ID: 25702102)
1. Follicular variant of papillary thyroid carcinoma (FVPTC): histological features, BRAF V600E mutation, and lymph node status.
Walts AE; Mirocha JM; Bose S
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1749-56. PubMed ID: 25702102
[TBL] [Abstract][Full Text] [Related]
2. The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases.
Eloy C; Santos J; Soares P; Sobrinho-Simões M
Virchows Arch; 2011 Sep; 459(3):265-76. PubMed ID: 21796448
[TBL] [Abstract][Full Text] [Related]
3. Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.
Eloy C; Santos J; Soares P; Sobrinho-Simões M
Virchows Arch; 2011 Dec; 459(6):595-605. PubMed ID: 22081104
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Transcriptomic and Genomic Profiling of Subtypes of Follicular Variant of Papillary Thyroid Carcinoma.
Song YS; Won JK; Yoo SK; Jung KC; Kim MJ; Kim SJ; Cho SW; Lee KE; Yi KH; Seo JS; Park YJ
Thyroid; 2018 Nov; 28(11):1468-1478. PubMed ID: 30226444
[TBL] [Abstract][Full Text] [Related]
5. Follicular variant of papillary thyroid cancer: encapsulated, nonencapsulated, and diffuse: distinct biologic and clinical entities.
Gupta S; Ajise O; Dultz L; Wang B; Nonaka D; Ogilvie J; Heller KS; Patel KN
Arch Otolaryngol Head Neck Surg; 2012 Mar; 138(3):227-33. PubMed ID: 22431868
[TBL] [Abstract][Full Text] [Related]
6. BRAF and RAS Mutational Status in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Invasive Subtype of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma in Korea.
Kim M; Jeon MJ; Oh HS; Park S; Kim TY; Shong YK; Kim WB; Kim K; Kim WG; Song DE
Thyroid; 2018 Apr; 28(4):504-510. PubMed ID: 29439609
[TBL] [Abstract][Full Text] [Related]
7. Application of Strict Criteria for Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Encapsulated Follicular Variant Papillary Thyroid Carcinoma: a Retrospective Study of 50 Tumors Previously Diagnosed as Follicular Variant PTC.
Point du Jour K; du Jour KP; Schmitt AC; Chen AY; Griffith CC
Endocr Pathol; 2018 Mar; 29(1):35-42. PubMed ID: 29368294
[TBL] [Abstract][Full Text] [Related]
8. BRAF mutation in follicular variant of papillary thyroid carcinoma is associated with unfavourable clinicopathological characteristics and malignant features on ultrasonography.
Chai YJ; Kim SJ; Kim SC; Koo do H; Min HS; Lee KE; Kim JH; Youn YK
Clin Endocrinol (Oxf); 2014 Sep; 81(3):432-9. PubMed ID: 24548081
[TBL] [Abstract][Full Text] [Related]
9. Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of RAS mutation testing.
Lee SR; Jung CK; Kim TE; Bae JS; Jung SL; Choi YJ; Kang CS
Thyroid; 2013 Nov; 23(11):1416-22. PubMed ID: 23590130
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the BRAF V600E mutation status and the clinicopathologic features of papillary thyroid carcinoma.
Shi CL; Sun Y; Ding C; Lv YC; Qin HD
Genet Mol Res; 2015 Jul; 14(3):7377-85. PubMed ID: 26214416
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for central neck lymph node metastases in follicular variant vs. classic papillary thyroid carcinoma.
Raffaelli M; De Crea C; Sessa L; Fadda G; Lombardi CP; Bellantone R
Endocrine; 2018 Oct; 62(1):64-70. PubMed ID: 29770933
[TBL] [Abstract][Full Text] [Related]
12. Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF (V600E) Harboring Pediatric Papillary Thyroid Carcinomas.
Onder S; Ozturk Sari S; Yegen G; Sormaz IC; Yilmaz I; Poyrazoglu S; Sanlı Y; Giles Senyurek Y; Kapran Y; Mete O
Endocr Pathol; 2016 Jun; 27(2):153-61. PubMed ID: 26951110
[TBL] [Abstract][Full Text] [Related]
13. The correlation of sodium iodide symporter and BRAF(V600E) mutation in classical variant papillary thyroid carcinoma.
Yazgan A; Yıldırım N; Gözalan A; Gümüştaş S; Kılıçarslan A; Balci S; Aydın C; Ersoy R; Cakir B; Güler G
Ann Diagn Pathol; 2016 Jun; 22():58-62. PubMed ID: 27180062
[TBL] [Abstract][Full Text] [Related]
14. Navigating the management of follicular variant papillary thyroid carcinoma subtypes: a classic PTC comparison.
Finnerty BM; Kleiman DA; Scognamiglio T; Aronova A; Beninato T; Fahey TJ; Zarnegar R
Ann Surg Oncol; 2015 Apr; 22(4):1200-6. PubMed ID: 25297901
[TBL] [Abstract][Full Text] [Related]
15. Role of Ultrasound in Predicting Tumor Invasiveness in Follicular Variant of Papillary Thyroid Carcinoma.
Hahn SY; Shin JH; Oh YL; Kim TH; Lim Y; Choi JS
Thyroid; 2017 Sep; 27(9):1177-1184. PubMed ID: 28699414
[TBL] [Abstract][Full Text] [Related]
16. [Mutation of RAS gene in follicular-differentiated thyroid tumors and its significance].
Liu LP; Hao JY; Pan H; Wang C; Yue P
Zhonghua Bing Li Xue Za Zhi; 2020 Mar; 49(3):256-261. PubMed ID: 32187898
[No Abstract] [Full Text] [Related]
17. Molecular Profile and Clinicopathologic Features of Follicular Variant Papillary Thyroid Carcinoma.
Sohn SY; Lee JJ; Lee JH
Pathol Oncol Res; 2020 Apr; 26(2):927-936. PubMed ID: 30900082
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of
Kim H; Kim BH; Kim YK; Kim JM; Oh SY; Kim EH; Lee MJ; Kim JH; Jeon YK; Kim SS; Lee BJ; Kim YK; Kim IJ
J Korean Med Sci; 2018 Jul; 33(27):e75. PubMed ID: 29962924
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics of Subtypes of Follicular Variant Papillary Thyroid Carcinoma.
Kim MJ; Won JK; Jung KC; Kim JH; Cho SW; Park DJ; Park YJ
Thyroid; 2018 Mar; 28(3):311-318. PubMed ID: 29343212
[TBL] [Abstract][Full Text] [Related]
20. Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP).
Strickland KC; Eszlinger M; Paschke R; Angell TE; Alexander EK; Marqusee E; Nehs MA; Jo VY; Lowe A; Vivero M; Hollowell M; Qian X; Wieczorek T; French CA; Teot LA; Cibas ES; Lindeman NI; Krane JF; Barletta JA
Endocr Pathol; 2018 Mar; 29(1):68-74. PubMed ID: 29396809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
